Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. Hosting Providers
  16. CDN Services

We are analyzing https://www.nature.com/articles/cddis2016306.

Title:
MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis | Cell Death & Disease
Description:
Altered expression of microRNA-590-5p (miR-590-5p) is involved in tumorigenesis, however, its role in colorectal cancer (CRC) remains to be determined. In this study, we focused on examining the effects of different expression levels of miR-590-5p in cancer cells and normal cells. Results showed that there are lower expression levels of miR-590-5p in human CRC cells and tissues than in normal control cells and tissues. Similarly, in our xenograft mouse model, knockdown of miR-590-5p promoted the progression of CRC. However, an overexpression of miR-590-5p in the mice inhibited angiogenesis, tumor growth, and lung metastasis. Nuclear factor 90 (NF90), a positive regulator of vascular endothelial growth factor (VEGF) mRNA stability and protein synthesis, was shown to be a direct target of miR-590-5p. The overexpression of NF90 restored VEGFA expression and rescued the loss of tumor angiogenesis caused by miR-590-5p. Conversely, the NF90-shRNA attenuated the increased tumor progression caused by the miR-590-5p inhibitor. Clinically, the levels of miR-590-5p were inversely correlated with those of NF90 and VEGFA in CRC tissues. Furthermore, knockdown of NF90 lead to a reduction of pri-miR-590 and an increase of mature miR-590-5p, suggesting a negative feedback loop between miR-590-5p and NF90. Collectively, these data establish miR-590-5p as an anti-onco-miR that inhibits CRC angiogenesis and metastasis through a new mechanism involving NF90/VEGFA signaling axis, highlighting the potential of miR-590-5p as a target for human CRC therapy.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {πŸ“š}

  • Science
  • Education
  • Health & Fitness

Content Management System {πŸ“}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {πŸ“ˆ}

What is the average monthly size of nature.com audience?

πŸŒ† Monumental Traffic: 20M - 50M visitors per month


Based on our best estimate, this website will receive around 42,554,915 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {πŸ’Έ}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {πŸ’°}


Display Ads {🎯}

$536,300 per month
Our calculations suggest that Nature.com earns between $357,503 and $983,134 monthly online from display advertisements.

Keywords {πŸ”}

mirp, crc, cells, expression, pubmed, cancer, cell, article, figure, google, scholar, angiogenesis, tumor, vegfa, control, levels, cas, protein, colorectal, metastasis, central, primir, compared, growth, tissues, normal, mice, mirna, nature, factor, human, knockdown, results, significantly, assay, analysis, negative, mirnas, found, transfected, min, role, vegf, target, inhibitor, mature, gene, performed, china, usa,

Topics {βœ’οΈ}

open-access journal published nature publishing group nature portfolio phu6-puro-nf90-shrna lentivirus particles privacy policy mir-590-5p-dependent post-transcriptional repression nature advertising bioinformatics tools ethanol solutions sheep anti-dig-horseradish peroxidase mir-590-5p-deleted cells grown sheep anti-dig-hrp conjugate putative mir-590-5p-binding site 0/ reprints mir-590-5p-deleted crc cells vegfa small-interfering rna mir-590-5p knockdown-induced angiogenesis data establish mir-590-5p enzyme-linked immunosorbent assay sw480-mir-590-5p inhibitor group ht29 mir-590-5p-deficient cells hrp-conjugated secondary antibody microrna-15b-5p shuttled mir-590-5p significantly reduced nf45/nf90 heterodimer contributes anti-rabbit secondary antibody rna-induced silencing complex dna-binding complex regulating squamous cell carcinoma 6 μm-thick paraffin sections strong pro-metastasis phenotype author correspondence mir-590-5p sponge inhibitor hrp substrate 3-amino-9-ethylcarbazole radio-immunoprecipitation assay buffer sw620-mir-590-5p groups 100 nm psicheck-2-nf90 3β€²utr mir-590-5p target sequence colorectal cancer inhibits synthetic mir-590-5p mimic cold serum-free medium 200 μl serum-free medium increases mature mir-590-5p sw620-mir-590-5p group compared sw620-mir-590-5p clones inhibiting nf90/vegfa axis pgem-t-easy vector brain-enriched mir-7 biogenesis wild-type hct116 cells

Questions {❓}

  • NF90 isoforms, a new family of cellular proteins involved in viral replication?

Schema {πŸ—ΊοΈ}

WebPage:
      mainEntity:
         headline:MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis
         description:Altered expression of microRNA-590-5p (miR-590-5p) is involved in tumorigenesis, however, its role in colorectal cancer (CRC) remains to be determined. In this study, we focused on examining the effects of different expression levels of miR-590-5p in cancer cells and normal cells. Results showed that there are lower expression levels of miR-590-5p in human CRC cells and tissues than in normal control cells and tissues. Similarly, in our xenograft mouse model, knockdown of miR-590-5p promoted the progression of CRC. However, an overexpression of miR-590-5p in the mice inhibited angiogenesis, tumor growth, and lung metastasis. Nuclear factor 90 (NF90), a positive regulator of vascular endothelial growth factor (VEGF) mRNA stability and protein synthesis, was shown to be a direct target of miR-590-5p. The overexpression of NF90 restored VEGFA expression and rescued the loss of tumor angiogenesis caused by miR-590-5p. Conversely, the NF90-shRNA attenuated the increased tumor progression caused by the miR-590-5p inhibitor. Clinically, the levels of miR-590-5p were inversely correlated with those of NF90 and VEGFA in CRC tissues. Furthermore, knockdown of NF90 lead to a reduction of pri-miR-590 and an increase of mature miR-590-5p, suggesting a negative feedback loop between miR-590-5p and NF90. Collectively, these data establish miR-590-5p as an anti-onco-miR that inhibits CRC angiogenesis and metastasis through a new mechanism involving NF90/VEGFA signaling axis, highlighting the potential of miR-590-5p as a target for human CRC therapy.
         datePublished:2016-10-13T00:00:00Z
         dateModified:2016-10-13T00:00:00Z
         pageStart:e2413
         pageEnd:e2413
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/cddis.2016.306
         keywords:
            Cell signalling
            Colorectal cancer
            Metastasis
            miRNAs
            Life Sciences
            general
            Biochemistry
            Cell Biology
            Immunology
            Cell Culture
            Antibodies
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig3_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig4_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig5_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig6_HTML.jpg
         isPartOf:
            name:Cell Death & Disease
            issn:
               2041-4889
            volumeNumber:7
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Qingxin Zhou
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuekun Zhu
               affiliation:
                     name:The First Affiliated Hospital of Harbin Medical University
                     address:
                        name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xiaoli Wei
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jianhua Zhou
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liang Chang
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Neurosurgery, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hong Sui
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu Han
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Daxun Piao
               affiliation:
                     name:The First Affiliated Hospital of Harbin Medical University
                     address:
                        name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Ruihua Sha
               affiliation:
                     name:Hongqi Hospital, Mudanjiang Medical University
                     address:
                        name:Department of Digestive Disease, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yuxian Bai
               affiliation:
                     name:The Third Affiliated Hospital, Harbin Medical University
                     address:
                        name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:MiR-590-5p inhibits colorectal cancer angiogenesis and metastasis by regulating nuclear factor 90/vascular endothelial growth factor A axis
      description:Altered expression of microRNA-590-5p (miR-590-5p) is involved in tumorigenesis, however, its role in colorectal cancer (CRC) remains to be determined. In this study, we focused on examining the effects of different expression levels of miR-590-5p in cancer cells and normal cells. Results showed that there are lower expression levels of miR-590-5p in human CRC cells and tissues than in normal control cells and tissues. Similarly, in our xenograft mouse model, knockdown of miR-590-5p promoted the progression of CRC. However, an overexpression of miR-590-5p in the mice inhibited angiogenesis, tumor growth, and lung metastasis. Nuclear factor 90 (NF90), a positive regulator of vascular endothelial growth factor (VEGF) mRNA stability and protein synthesis, was shown to be a direct target of miR-590-5p. The overexpression of NF90 restored VEGFA expression and rescued the loss of tumor angiogenesis caused by miR-590-5p. Conversely, the NF90-shRNA attenuated the increased tumor progression caused by the miR-590-5p inhibitor. Clinically, the levels of miR-590-5p were inversely correlated with those of NF90 and VEGFA in CRC tissues. Furthermore, knockdown of NF90 lead to a reduction of pri-miR-590 and an increase of mature miR-590-5p, suggesting a negative feedback loop between miR-590-5p and NF90. Collectively, these data establish miR-590-5p as an anti-onco-miR that inhibits CRC angiogenesis and metastasis through a new mechanism involving NF90/VEGFA signaling axis, highlighting the potential of miR-590-5p as a target for human CRC therapy.
      datePublished:2016-10-13T00:00:00Z
      dateModified:2016-10-13T00:00:00Z
      pageStart:e2413
      pageEnd:e2413
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/cddis.2016.306
      keywords:
         Cell signalling
         Colorectal cancer
         Metastasis
         miRNAs
         Life Sciences
         general
         Biochemistry
         Cell Biology
         Immunology
         Cell Culture
         Antibodies
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig3_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig4_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig5_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fcddis.2016.306/MediaObjects/41419_2016_Article_BFcddis2016306_Fig6_HTML.jpg
      isPartOf:
         name:Cell Death & Disease
         issn:
            2041-4889
         volumeNumber:7
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Qingxin Zhou
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuekun Zhu
            affiliation:
                  name:The First Affiliated Hospital of Harbin Medical University
                  address:
                     name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xiaoli Wei
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jianhua Zhou
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liang Chang
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Neurosurgery, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hong Sui
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu Han
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Daxun Piao
            affiliation:
                  name:The First Affiliated Hospital of Harbin Medical University
                  address:
                     name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Ruihua Sha
            affiliation:
                  name:Hongqi Hospital, Mudanjiang Medical University
                  address:
                     name:Department of Digestive Disease, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yuxian Bai
            affiliation:
                  name:The Third Affiliated Hospital, Harbin Medical University
                  address:
                     name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cell Death & Disease
      issn:
         2041-4889
      volumeNumber:7
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The First Affiliated Hospital of Harbin Medical University
      address:
         name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Neurosurgery, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
      name:The First Affiliated Hospital of Harbin Medical University
      address:
         name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
         type:PostalAddress
      name:Hongqi Hospital, Mudanjiang Medical University
      address:
         name:Department of Digestive Disease, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China
         type:PostalAddress
      name:The Third Affiliated Hospital, Harbin Medical University
      address:
         name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Qingxin Zhou
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Yuekun Zhu
      affiliation:
            name:The First Affiliated Hospital of Harbin Medical University
            address:
               name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Xiaoli Wei
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Jianhua Zhou
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Liang Chang
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Neurosurgery, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Hong Sui
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Yu Han
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Daxun Piao
      affiliation:
            name:The First Affiliated Hospital of Harbin Medical University
            address:
               name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      name:Ruihua Sha
      affiliation:
            name:Hongqi Hospital, Mudanjiang Medical University
            address:
               name:Department of Digestive Disease, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China
               type:PostalAddress
            type:Organization
      name:Yuxian Bai
      affiliation:
            name:The Third Affiliated Hospital, Harbin Medical University
            address:
               name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of Neurosurgery, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China
      name:Department of General Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, China
      name:Department of Digestive Disease, Hongqi Hospital, Mudanjiang Medical University, Mudanjiang, China
      name:Department of Gastrointestinal Oncology, The Third Affiliated Hospital, Harbin Medical University, Harbin, China

Social Networks {πŸ‘}(1)

External Links {πŸ”—}(158)

Analytics and Tracking {πŸ“Š}

  • Google Tag Manager

Libraries {πŸ“š}

  • Prism.js
  • Zoom.js

Emails and Hosting {βœ‰οΈ}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk

CDN Services {πŸ“¦}

  • Crossref

4.92s.